Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Argentina Lithium (V.LIT) Announces US$90 Million Investment by Stellantis (click to learn more) ApartmentLove (C.APLV) Integrates OwnerDirect.com with Google to Display Vacation Rental Listings Worldwide (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News NurExone Biologic Inc V.NRX

Alternate Symbol(s):  NRXBF

Metals & Mining Industrial Metals & Minerals
NurExone Biologic Inc. is a biopharmaceutical company. The Company is developing and commercializing an exosome therapy ExoTherapy production platform and products for a global market. It is involved in the development of ExoPTEN, the first ExoTherapy-based product for acute Spinal Cord Injuries (SCI). The Company is developing treatment for the reversal or reduction of paralysis following... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (TSXV:NRX)

NurExone Appoints Dr. Reuter Investor Relations in Europe

GlobeNewswire 17 hours ago

The Watchlist by The Market Herald Releases New Interviews with NurExone Biologic and SuperBuzz Discussing Their Latest News

Accesswire September 13, 2023

NurExone Moves Forward Towards Human Clinical Trials, Completes Pre-IND Meeting with the FDA for Proprietary ExoPTEN Drug

GlobeNewswire September 13, 2023

NurExone Announces Closing of Second Tranche of Private Placement, bringing total raise at this round to approximately CAD$1.5M

GlobeNewswire September 6, 2023

NurExone Reports Second Quarter 2023 Financial Results and Provides Corporate Update

GlobeNewswire August 28, 2023

NurExone Announces Private Placement

GlobeNewswire August 9, 2023

NurExone Biologic Announces Advancements in Extracellular Vesicles Functionality with Enhanced Potency and Cellular Uptake for potentially better drug delivery

GlobeNewswire July 20, 2023

NurExone Announces Appointment of New Director and Provides Corporate Updates

Newsfile July 7, 2023

Regeneration and Reinnervation of Spinal Cord in Rats Treated with NurExone's Intranasal ExoPTEN

GlobeNewswire June 22, 2023
View More News ››

Opinion & Analysis (TSXV:NRX)

ExoTherapy offers hope for treating acute spinal cord injuries

Brieanna McCutcheon  9 days ago
View More Opinion ››

Bullboard Posts (TSXV:NRX)

NurExone Moves Forward Towards Human Clinical Trials, Comple

Taking a starter psotion here. 
RealREIT$ - September 13, 2023

NurExone Moves Forward Towards Human Clinical Trials

https://www.globenewswire.com/news-release/2023/09/13/2742459/0/en/NurExone-Moves-Forward-Towards-Human-Clinical-Trials-Completes-Pre-IND...
RealREIT$ - September 13, 2023

Regeneration & Reinnervation of Spinal Cord in Rats Treated

TORONTO and TEL AVIV, Israel, June 22, 2023 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. ("NurExone" or the "Company") ...
Betteryear2 - June 22, 2023

NurExone: Loading Exosomes with Therapeutic Molecules

NurExone reported today results of a pre-clinical loading efficiency study that was completed by the Company showing that its innovative...
ThesisCapital - November 30, 2022

Progress Update on RTO with Nurexone Biologic

Hot off the press: Calgary, Alberta--(Newsfile Corp. - March 15, 2022) - EnerSpar Corp. (TSXV: ENER) (FSE: 5E0) ("...
dkeller85 - March 20, 2022

February 2020

EnerSpar Announces MindFull Amending Agreement and Appointment of Director Newsfile Corp. NewsfileDecember 9, 2019, 7:18 AM MST Calgary...
HappyHappy - December 9, 2019
View more Bullboard ››

GoGold Resources Inc

GoGold Resources Inc

GoGold Resources Inc. is a Canada-based silver and gold producer. The principal business of the Company is the exploration ...
View More »